Drug developer Abraxis Biosciences Inc. has added to its large portfolio of generic drugs with U.S. regulatory approval of its generic version of Unasyn, a treatment for bacterial infections. The U.S.
Mylan announced the launch of Ampicillin and Sulbactam for Injection, the generic version of Pfizer’s Unasyn. Unasyn is an antibiotic that combines ampicillin, a broad-spectrum penicillin, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results